Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced the appointment of Jay Backstrom ...

Use of lasers for dermatologic conditions in pediatric patients brings challenges, from psychosocial and informed consent issues to pain management.